Researchers found that the odds of developing an eye condition that leads to vision loss were about 5 times higher among ...

Officials wrote that Novo Nordisk had failed to failed to report ‘serious and unexpected’ adverse drug experiences ...

Kim Wohlwend with Midwest Mind and Body Healthcare said the pill version of Wegovy is not just beneficial for patients who are scared of needles."Somebody who travels a lot should maybe look more at ...

March 9 (Reuters) - Hims & Hers' shares were up over 40% on Monday, after Novo Nordisk agreed to sell its blockbuster Wegovy ...

The Danish drugmaker sued Hims in February over compounded versions of the Wegovy weight-loss pill that Hims launched and ...

By Stine Jacobsen and Maggie Fick COPENHAGEN, March 9 (Reuters) - Novo Nordisk has agreed to sell its blockbuster Wegovy and Ozempic drugs through U.S. telehealth company Hims & Hers' platform, the ...

A new battle between these longtime rival companies will likely go the same way as their previous battles.

In this video, the creator shares their experience after discontinuing "fat jabs," highlighting the expected changes that occurred. The video provides insights into the effects of stopping this ...

The FDA sent a warning letter this month to Novo Nordisk, alleging the drugmaker failed to report, in a timely manner, ...

Wegovy is a Food and Drug Administration-approved weight loss medication for people with obesity or those who are overweight with weight-related health conditions. In recent years, interest in ...

Telehealth company Hims & Hers dropped its plan to offer a knockoff version of the weight-loss pill Wegovy on Saturday — two days after it announced the new drug ...

The price of the company's popular GLP-1 drugs could come down by as much as 50% next year.